Literature DB >> 20842411

Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Alamelu Mahalingam1, Eric Smith, Judit Fabian, Festo R Damian, Jennifer J Peters, Meredith R Clark, David R Friend, David F Katz, Patrick F Kiser.   

Abstract

PURPOSE: Develop a preclinical in vitro algorithm enabling de novo design of semisolid vaginal drug delivery gels, by using biomechanical modeling of gel spreading in the vaginal canal and empirically relating gel composition to mechanical properties and predicted performance.
METHODS: Gel performance was defined through a multivariate objective function constructed from gels' mechanical properties and selected performance criteria for gel spreading within the vaginal canal. Mixture design of experiment was used to establish a semi-empirical relationship linking composition-property and property-performance relationships for gels with varying concentrations of hydroxyethylcellulose and Carbopol 974P. This permits definition of a local optimum for gel composition and volume of administration, within a defined gel composition space.
RESULTS: Rheological behavior and, consequently, the value of the objective function varied broadly with composition. The algorithm indicated a 3.0 wt% HEC gel as the near optimal composition for a 3.5 mL applied volume for gels designed to spread throughout the vagina.
CONCLUSIONS: The algorithm introduced herein is a novel tool that facilitates an understanding of the composition-property-performance relationship for vaginal semisolid drug delivery gels. This approach has promise as a scientific methodology for evaluation and optimization of vaginal gels prior to in vivo investigations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842411     DOI: 10.1007/s11095-010-0244-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  38 in total

Review 1.  A vaginal fluid simulant.

Authors:  D H Owen; D F Katz
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

Review 2.  Intravaginal gels as drug delivery systems.

Authors:  Mary Justin-Temu; Festo Damian; Renaat Kinget; Guy Van Den Mooter
Journal:  J Womens Health (Larchmt)       Date:  2004-09       Impact factor: 2.681

3.  The optimal analysis of MRI data to quantify the distribution of a microbicide.

Authors:  Kurt T Barnhart; E Scott Pretorius; David M Shera; Mayadah Shabbout; Alka Shaunik
Journal:  Contraception       Date:  2005-09-19       Impact factor: 3.375

Review 4.  Gels as vaginal drug delivery systems.

Authors:  J das Neves; M F Bahia
Journal:  Int J Pharm       Date:  2006-03-17       Impact factor: 5.875

5.  In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection.

Authors:  Katty Terrazas-Aranda; Yven Van Herrewege; Paul J Lewi; Jens Van Roey; Guido Vanham
Journal:  Antivir Chem Chemother       Date:  2007

6.  A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding.

Authors:  Andrew J Szeri; Su Chan Park; Stéphane Verguet; Aaron Weiss; David F Katz
Journal:  Phys Fluids (1994)       Date:  2008-08-21       Impact factor: 3.521

7.  Cyclic changes in the vaginal epithelium of normal rhesus macaques.

Authors:  B Poonia; L Walter; J Dufour; R Harrison; P A Marx; R S Veazey
Journal:  J Endocrinol       Date:  2006-09       Impact factor: 4.286

8.  Interpreting properties of microbicide drug delivery gels: analyzing deployment kinetics due to squeezing.

Authors:  Sarah L Kieweg; David F Katz
Journal:  J Pharm Sci       Date:  2007-04       Impact factor: 3.534

9.  Whither or wither microbicides?

Authors:  Robert M Grant; Dean Hamer; Thomas Hope; Rowena Johnston; Joep Lange; Michael M Lederman; Judy Lieberman; Christopher J Miller; John P Moore; Donald E Mosier; Douglas D Richman; Robert T Schooley; Marty S Springer; Ronald S Veazey; Mark A Wainberg
Journal:  Science       Date:  2008-07-25       Impact factor: 47.728

10.  Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa.

Authors:  Gita Ramjee; Neetha S Morar; Sarah Braunstein; Barbara Friedland; Heidi Jones; Janneke van de Wijgert
Journal:  AIDS Res Ther       Date:  2007-09-27       Impact factor: 2.250

View more
  20 in total

1.  The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle.

Authors:  Savas Tasoglu; Jennifer J Peters; Su Chan Park; Stéphane Verguet; David F Katz; Andrew J Szeri
Journal:  Phys Fluids (1994)       Date:  2011-09-15       Impact factor: 3.521

2.  Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.

Authors:  José A Fernández-Romero; Ciby J Abraham; Aixa Rodriguez; Larisa Kizima; Ninochka Jean-Pierre; Radhika Menon; Othell Begay; Samantha Seidor; Brian E Ford; Pedro I Gil; Jennifer Peters; David Katz; Melissa Robbiani; Thomas M Zydowsky
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

Review 4.  Vaginal drug distribution modeling.

Authors:  David F Katz; Andrew Yuan; Yajing Gao
Journal:  Adv Drug Deliv Rev       Date:  2015-04-28       Impact factor: 15.470

5.  Coupled gel spreading and diffusive transport models describing microbicidal drug delivery.

Authors:  Claire Funke; Kelsey MacMillan; Anthony Ham; Andrew J Szeri; David F Katz
Journal:  Chem Eng Sci       Date:  2016-05-12       Impact factor: 4.311

6.  pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.

Authors:  Tao Zhang; Timothy F Sturgis; Bi-Botti C Youan
Journal:  Eur J Pharm Biopharm       Date:  2011-06-26       Impact factor: 5.571

7.  Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model.

Authors:  Marilyn Cost; Charlene S Dezzutti; Meredith R Clark; David R Friend; Ayman Akil; Lisa Cencia Rohan
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

8.  Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc.

Authors:  Claire J Forbes; Deborah Lowry; Leslie Geer; Ronald S Veazey; Robin J Shattock; Per Johan Klasse; Mark Mitchnick; Laurie Goldman; Lara A Doyle; Brendan C O Muldoon; A David Woolfson; John P Moore; R Karl Malcolm
Journal:  J Control Release       Date:  2011-08-12       Impact factor: 9.776

9.  Transient spreading and swelling behavior of a gel deploying an anti-HIV topical microbicide.

Authors:  Savas Tasoglu; David F Katz; Andrew J Szeri
Journal:  J Nonnewton Fluid Mech       Date:  2012-11       Impact factor: 2.670

10.  Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design.

Authors:  Kate Morrow Guthrie; Shira Dunsiger; Sara E Vargas; Joseph L Fava; Julia G Shaw; Rochelle K Rosen; Patrick F Kiser; E Milu Kojic; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-29       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.